More on KZIA

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (9/9/25 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Kazia Therapeutics (NQ:KZIA)
Delayed: 7.25 -0.15 (2.03%)
Prev. Close $7.40  
Open$7.44 
52 Wk High$ 
52 Wk Low$ 
Day High$7.79 
Day Low$7.15 
P/E N/A  
EPS$ 
Volume276,310 

Friends, Peers and Foes (?): KZA, VENU, BNTX NTHI (more...)

Oct 2, 2026 03:57 PM Form SCHEDULE 13G/A KAZIA THERAPEUTICS LTD Filed by: Dauntless Investment Group, LLC
Sep 28, 2026 06:05 AM Form EFFECT Kazia Therapeutics Limit
Sep 22, 2026 08:04 AM Form 424B3 KAZIA THERAPEUTICS LTD
Sep 22, 2026 08:03 AM Form 424B3 KAZIA THERAPEUTICS LTD
Sep 22, 2026 08:03 AM Form 424B3 KAZIA THERAPEUTICS LTD
Sep 22, 2026 08:01 AM Form 424B3 KAZIA THERAPEUTICS LTD
Sep 22, 2026 08:00 AM Form 6-K KAZIA THERAPEUTICS LTD For: Sep 22
Sep 22, 2026 07:30 AM Sovargen doses first patient in paxalisib epilepsy trial, triggering $2M payment
Sep 22, 2026 07:30 AM Kazia Therapeutics Announces Sovargen Co. Doses First Patient in Phase 1b/2a Trial of Paxalisib for Rare Seizure Disorders
Sep 18, 2026 04:04 PM Form 424B3 KAZIA THERAPEUTICS LTD
View All Articles

Entities mentioned with KZIA

View All Entities